Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial - Ray, Kausik K; Colhoun, Helen M; Szarek, Michael; Baccara-dinet, Marie; Bhatt, Deepak L; Bittner, Vera A; Budaj, Andrzej J; Diaz, Rafael; Goodman, Shaun G; Nicolau, José Carlos (Lancet diabetes & endocrinology, 2019)